Cytokine profile, Treg/Th17 cell frequency changes during different posttransplantational time points in patients undergoing renal transplantation.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
11 2019
Historique:
received: 21 01 2019
revised: 26 03 2019
accepted: 05 04 2019
pubmed: 24 4 2019
medline: 2 6 2020
entrez: 24 4 2019
Statut: ppublish

Résumé

Renal transplantation is the best therapeutic approach for end stage renal dysfunction patients. There are direct relationships between proportions of Treg cells, Treg/Th17 cells ratio and secreted immunosuppressive cytokines with increased survival rate of the transplanted organ. The aim of this study was the measurement of Treg and Th17 cells frequency and their secreted cytokines. Ninety renal-transplanted patients were divided in three groups based on times after transplantation (1-6 month, 6-36 month, and more than 3 years). Treg and Th17 cells frequency, expression level of their transcription factors and cytokines, and their secreted cytokines level were measured in these groups. Higher expression level of Interleukin (IL)-10 and FoxP3 mRNA were observed in patients who had longer posttransplantation time. In contrast, lower mRNA expressions of IL-6, IL-17, IL-23, and TGF-β were observed in this group. Receptor γt showed no significant changes in studied groups. In addition IL-10 level was increased and IL-6, IL-17, IL-23, and TGF-β level were decreased in patients who had longer posttransplantation time. Treg cells frequency was raised in mentioned group whereas no remarkable changes were observed in Th17 cell frequency. The present study declared that in stable renal transplantation, over time, the percentage of Treg cells and Treg/Th17 ration is increased. This increase in ratio induces a change in cytokine profile, resulting in an increased immunosuppressive cytokines such as IL-10 leading to increase in the survival rate of the transplanted organ.

Identifiants

pubmed: 31012117
doi: 10.1002/jcp.28698
doi:

Substances chimiques

Cytokines 0
RNA, Messenger 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20935-20943

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Hamid Mortazavi (H)

Research Center for Chronic Kidney Disease, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Sadegh Soltani-Zangbar (MS)

Student committee Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Stem Cells Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Shadi Eghbal-Fard (S)

Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Amir Mehdizadeh (A)

Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Amin Kamrani (A)

Stem Cells Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Forough Chakeri-Khiavi (F)

Stem Cells Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Hossein Samadi Kafil (HS)

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Farhad Jadidi-Niaragh (F)

Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Shahrzad Rahimifar (S)

Sanofi Medical Department, Tehran, Iran.

Hamid Tayebi Khosroshahi (HT)

Research Center for Chronic Kidney Disease, Tabriz University of Medical Sciences, Tabriz, Iran.

Mehdi Yousefi (M)

Stem Cells Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH